Pieris Pharmaceuticals Inc (PIRS)
16.26
+0.33
(+2.05%)
USD |
NASDAQ |
Nov 22, 11:23
Pieris Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -9.23K% |
| December 31, 2023 | -352.9% |
| September 30, 2023 | -55.08% |
| June 30, 2023 | 19.83% |
| March 31, 2023 | -680.9% |
| December 31, 2022 | -138.6% |
| September 30, 2022 | -181.3% |
| June 30, 2022 | -279.6% |
| March 31, 2022 | -46.42% |
| December 31, 2021 | -112.9% |
| September 30, 2021 | -407.6% |
| June 30, 2021 | -471.8% |
| March 31, 2021 | -26.69% |
| December 31, 2020 | -767.2% |
| September 30, 2020 | -486.0% |
| June 30, 2020 | -44.02% |
| March 31, 2020 | -27.12% |
| December 31, 2019 | -4.46% |
| Date | Value |
|---|---|
| September 30, 2019 | -17.13% |
| June 30, 2019 | -220.5% |
| March 31, 2019 | -121.1% |
| December 31, 2018 | -237.7% |
| September 30, 2018 | -73.73% |
| June 30, 2018 | -1.74% |
| March 31, 2018 | -209.9% |
| December 31, 2017 | 41.27% |
| September 30, 2017 | -179.8% |
| June 30, 2017 | -544.3% |
| March 31, 2017 | -595.2% |
| December 31, 2016 | -240.5% |
| September 30, 2016 | -789.3% |
| June 30, 2016 | -548.4% |
| March 31, 2016 | -333.8% |
| December 31, 2015 | -135.2% |
| September 30, 2015 | -963.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-9.23K%
Minimum
Mar 2024
19.83%
Maximum
Jun 2023
-738.5%
Average
-159.9%
Median
Profit Margin (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | -13.84% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |